Polydex Pharmaceuticals Valuation
Based on Macroaxis valuation methodology, the company cannot be evaluated at this time. Polydex Pharmaceuticals recent Real Value cannot be determined due to lack of data. The prevailing price of Polydex Pharmaceuticals is $0.0. Our model determines the value of Polydex Pharmaceuticals from analyzing the company fundamentals such as Shares Outstanding of 3.43 M, return on equity of -0.18, and Operating Margin of (0.22) % as well as examining its technical indicators and probability of bankruptcy.
Polydex Pharmaceuticals Total Value Analysis
Polydex Pharmaceuticals is at this time anticipated to have takeover price of 2.23 M with market capitalization of 2.23 M, debt of 301.49 K, and cash on hands of 870.3 K. Please note that takeover price may be misleading and is a subject to mistakes in financial statements. We encourage investors to thoroughly investigate all of the Polydex Pharmaceuticals fundamentals before making investing decisions based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
2.23 M | 2.23 M | 301.49 K | 870.3 K |
Polydex Pharmaceuticals Investor Information
The company has price-to-book ratio of 0.42. Typically companies with comparable Price to Book (P/B) are able to outperform the market in the long run. Polydex Pharmaceuticals recorded a loss per share of 0.13. The entity had not issued any dividends in recent years. The firm had 1:10 split on the 23rd of June 1997. Based on the key indicators related to Polydex Pharmaceuticals' liquidity, profitability, solvency, and operating efficiency, Polydex Pharmaceuticals is not in a good financial situation at this time. It has a very high probability of going through financial hardship in April.Polydex Pharmaceuticals Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Polydex Pharmaceuticals has an asset utilization ratio of 61.79 percent. This implies that the Company is making $0.62 for each dollar of assets. An increasing asset utilization means that Polydex Pharmaceuticals is more efficient with each dollar of assets it utilizes for everyday operations.Polydex Pharmaceuticals Profitability Analysis
The company reported the revenue of 4.05 M. Net Income was 0 with profit before overhead, payroll, taxes, and interest of 970.3 K.Please note that valuation analysis is one of the essential comprehensive assessments in business. It evaluates Polydex Pharmaceuticals' worth, which you can determine by considering its current assets, liabilities and future cash flows. The investors' valuation analysis is an important metric that will give you a perspective on different companies. It helps you know the worth of the potential investment in Polydex Pharmaceuticals and how it compares across the competition.
Polydex Pharmaceuticals Growth Indicators
Investing in growth stocks can be very risky. If the company such as Polydex Pharmaceuticals does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Quarterly Earnings Growth Y O Y | -0.374 | |
| Retained Earnings | -18.1 M |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in interest. You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Other Consideration for investing in Polydex Pink Sheet
If you are still planning to invest in Polydex Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Polydex Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Stocks Directory Find actively traded stocks across global markets |